Skip to main content

Clinical Neuroimmunology

The group of Clinical Neuroimmunology - Centre d'Esclerosi Múltiple de Catalunya (Cemcat) at the Vall d'Hebron Institut de Recerca (VHIR) is a multidisciplinary group dedicated to clinical assistance, physical and cognitive rehabilitation, and clinical and basic research on multiple sclerosis (MS). Cemcat is a national but also an international reference center in the clinical assistance of MS patients. The research performed in the group is divided and further combined in clinical and basic research. In addition, basic research has a marked translational character since the ultimate goal of the group is to improve the quality of life of patients suffering from MS, through in-depth knowledge of the pathogenic mechanisms of the disease and the development of new and more effective therapeutic approaches. 

Publications

Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.

PMID: 37861218
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2023
Reference: N Engl J Med. 2023 Oct 20. doi: 10.1056/NEJMoa2307980.
Impact factor:
Publication type: Paper in international publication
Authors: Abraldes, Juan Gonzalez; Ahn, Myung-Ju; Akamatsu, Hiroaki; Albillos, Agustin; Amitrano, Lucio; Anderson, Erik S; Balcar, Lorenz; Blackhall, Fiona; Borghaei, Hossein; Bosch, Jaime et al.
DOI: 10.1056/NEJMoa2307980

Correction: Revision surgery following long lumbopelvic constructs for adult spinal deformity: prospective experience from two dedicated databases.

PMID: 37906292
Journal: EUROPEAN SPINE JOURNAL
Year: 2023
Reference: Eur Spine J. 2023 Oct 31. doi: 10.1007/s00586-023-07988-8.
Impact factor:
Publication type: Other (letters to the editor, abstracts, corrigendum, etc.)
Authors: Alanay, Ahmet; Baldinotti, Anna; Bar-Or, Amit; Barkhof, Frederik; Haddad, Sleiman; Hauser, Stephen L; Kappos, Ludwig; Kleinstuck, Frank; Koendgen, Harold; Leppert, David et al.
DOI: 10.1007/s00586-023-07988-8

Ocrelizumab exposure in relapsing-remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension.

PMID: 37906326
Journal: JOURNAL OF NEUROLOGY
Year: 2023
Reference: J Neurol. 2023 Oct 31. doi: 10.1007/s00415-023-11943-4.
Impact factor:
Publication type: Paper in international publication
Authors: Baldinotti, Anna; Bar-Or, Amit; Barkhof, Frederik; Hauser, Stephen L; Kappos, Ludwig; Koendgen, Harold; Leppert, David; Li, David K B; Montalban, Xavier; Nedelcu, Marius et al.
DOI: 10.1007/s00415-023-11943-4

Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.

PMID: 37940409
Journal: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Year: 2023
Reference: J Neurol Neurosurg Psychiatry. 2023 Nov 8:jnnp-2023-332251. doi: 10.1136/jnnp-2023-332251.
Impact factor:
Publication type: Paper in international publication
Authors: Abdelhak, Ahmed; Alvarez-Lafuente, Roberto; Anton-Galindo, Ester; Bachhuber, Franziska; Benkert, Pascal; Berek, Klaus; Blanco, Yolanda; Cabana-Dominguez, Judit; Castillo-Trivino, Tamara; Comabella, Manuel et al.
DOI: 10.1136/jnnp-2023-332251

Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study.

PMID: 34716250
Journal: NEUROLOGY
Year: 2022
Reference: Neurology. 2022 Jan 4;98(1):e1-e14. doi: 10.1212/WNL.0000000000013016. Epub 2021 Oct 29.
Impact factor:
Publication type: Paper in international publication
Authors: Amato, Maria Pia; Barkhof, Frederik; Brownlee, Wallace; Ciccarelli, Olga; Comi, Giancarlo; Costa, Gloria Dalla; Cramer, Stig P; Drulovic, Jelena; Enzinger, Christian; Fainardi, Enrico et al.
DOI: 10.1212/WNL.0000000000013016

CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event.

PMID: 33870790
Journal: Multiple Sclerosis Journal
Year: 2022
Reference: Mult Scler. 2022 Jan;28(1):71-81. doi: 10.1177/13524585211010082. Epub 2021 Apr 19.
Impact factor:
Publication type: Paper in international publication
Authors: Auger, Cristina; Benkert, Pascal; Clarke, Margareta A; Comabella, Manuel; Fissolo, Nicolas; Granziera, Cristina; Kuhle, Jens; Montalban, Xavier; Pareto, Deborah; Pinteac, Rucsanda et al.
DOI: 10.1177/13524585211010082

Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey.

PMID: 33764197
Journal: Multiple Sclerosis Journal
Year: 2022
Reference: Mult Scler. 2022 Jan;28(1):132-138. doi: 10.1177/13524585211005339. Epub 2021 Mar 25.
Impact factor:
Publication type: Paper in international publication
Authors: Amato, Maria Pia; Derfuss, Tobias; Fonderico, Mattia; Hemmer, Bernhard; Portaccio, Emilio; Selmaj, Krzysztof; Stankoff, Bruno; Tintore, Mar et al.
DOI: 10.1177/13524585211005339

[Epidemiology of neuromyelitis optica spectrum. New and old challenges].

PMID: 34927702
Journal: REVISTA DE NEUROLOGIA
Year: 2022
Reference: Rev Neurol. 2022 Jan 1;74(1):22-34. doi: 10.33588/rn.7401.2021163.
Impact factor:
Publication type: Review in national publication
Authors: Arrambide, G; Cobo-Calvo, A; Sepulveda, M et al.
DOI: 10.33588/rn.7401.2021163

Opportunities for Understanding MS Mechanisms and Progression With MRI Using Large-Scale Data Sharing and Artificial Intelligence.

PMID: 34607924
Journal: NEUROLOGY
Year: 2021
Reference: Neurology. 2021 Nov 23;97(21):989-999. doi: 10.1212/WNL.0000000000012884. Epub 2021 Oct 4.
Impact factor: 9.91
Publication type: Paper in international publication
Authors: Barkhof, Frederik, Vrenken, Hugo, Jenkinson, Mark, Pham, Dzung, Guttmann, Charles R G, Pareto, Deborah, Paardekooper, Michel, de Sitter, Alexandra, Rocca, Maria A, Wottschel, Viktor et al.
DOI: 10.1212/WNL.0000000000012884

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.

PMID: 34610987
Journal: NEUROLOGY
Year: 2021
Reference: Neurology. 2021 Nov 9;97(19):e1870-e1885. doi: 10.1212/WNL.0000000000012753. Epub 2021 Oct 5.
Impact factor: 9.91
Publication type: Paper in international publication
Authors: Pirmani, Ashkan, Simpson-Yap, Steve, De Brouwer, Edward, Kalincik, Tomas, Rijke, Nick, Hillert, Jan A, Walton, Clare, Edan, Gilles, Moreau, Yves, Spelman, Tim et al.
DOI: 10.1212/WNL.0000000000012753

Monocyte-to-Lymphocyte Ratio in Clot Analysis as a Marker of Cardioembolic Stroke Etiology.

PMID: 34586594
Journal: Translational Stroke Research
Year: 2021
Reference: Transl Stroke Res. 2021 Sep 29. pii: 10.1007/s12975-021-00946-w. doi: 10.1007/s12975-021-00946-w.
Impact factor: 6.829
Publication type: Paper in international publication
Authors: Ribo, Marc, Juega, Jesus, Palacio-Garcia, Carlos, Rodriguez, Maite, Deck, Matias, Rodriguez-Luna, David, Requena, Manuel, Garcia-Tornel, Alvaro, Rodriguez-Villatoro, Noelia, Rubiera, Marta et al.
DOI: 10.1007/s12975-021-00946-w

Author Correction: Open-access quantitative MRI data of the spinal cord and reproducibility across participants, sites and manufacturers.

PMID: 34556662
Journal: Scientific Data
Year: 2021
Reference: Sci Data. 2021 Sep 23;8(1):251. doi: 10.1038/s41597-021-01044-0.
Impact factor: 6.444
Publication type: Letter or abstract
Authors: Horak, Tomas, Descoteaux, Maxime, de Sousa, Paulo Loureiro, Dostal, Marek, Doyon, Julien, Dvorak, Adam, Eippert, Falk, Epperson, Karla R, Epperson, Kevin S, Freund, Patrick et al.
DOI: 10.1038/s41597-021-01044-0

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

PMID: 31987648
Journal: Neurologia (Barcelona, Spain)
Year: 2020
Reference: Neurologia (Engl Ed). 2020 Jan 25:S0213-4853(19)30146-X. doi: 10.1016/j.nrl.2019.11.003.
Impact factor:
Publication type: Paper in national publication
Authors: Alvarez Cermeno, J C; Arnal Garcia, C; Arroyo Gonzalez, R; Brieva Ruiz, L; Calles Hernandez, C; Eichau Madueno, S; Fernandez Fernandez, O; Fernandez-Prada, M; Garcia Merino, A; Garcia Vazquez, E et al.
DOI: 10.1016/j.nrl.2019.11.003

Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).

PMID: 31960250
Journal: NEUROLOGICAL SCIENCES
Year: 2020
Reference: Neurol Sci. 2020 Jun;41(6):1513-1519. doi: 10.1007/s10072-019-04230-6. Epub 2020 Jan 20.
Impact factor:
Publication type: Paper in international publication
Authors: Alonso Serena, Marina; Alonso, Ricardo; Alvez Pinheiro, Amelia; Balbuena, Maria E; Barboza, Andres G; Bestoso, Santiago; Blanche, Jorge; Blaya, Patricio A; Burgos, Marcos; Cabrera, Lorena M et al.
DOI: 10.1007/s10072-019-04230-6

Biosensors to monitor MS activity.

PMID: 31965896
Journal: Multiple Sclerosis Journal
Year: 2020
Reference: Mult Scler. 2020 Apr;26(5):605-608. doi: 10.1177/1352458519888178. Epub 2020 Jan 22.
Impact factor:
Publication type: Paper in international publication
Authors: Graves, Jennifer S; Montalban, Xavier et al.
DOI: 10.1177/1352458519888178

Falls in People with Multiple Sclerosis: Risk Identification, Intervention, and Future Directions.

PMID: 33424479
Journal: International journal of MS care
Year: 2020
Reference: Int J MS Care. 2020 Nov-Dec;22(6):247-255. doi: 10.7224/1537-2073.2020-014. Epub 2020 Sep 14.
Impact factor: 0
Publication type: Paper in international publication
Authors: Coote, Susan, Santoyo-Medina, Carme, Kalron, Alon, Gunn, Hilary, Quinn, Gillian, Comber, Laura et al.
DOI: 10.7224/1537-2073.2020-014

[New drugs for the treatment of multiple sclerosis].

PMID: 29645067
Journal: REVISTA DE NEUROLOGIA
Year: 2018
Reference: Rev Neurol. 2018 Apr 16;66(8):253.
Impact factor: 0.601
Publication type: Editorail in international publication
Authors: Rio, J et al.
DOI:

Physiotherapeutic interventions in multiple sclerosis across Europe: Regions and other factors that matter.

PMID: 29579644
Journal: Multiple Sclerosis and Related Disorders
Year: 2018
Reference: Mult Scler Relat Disord. 2018 May;22:59-67. doi: 10.1016/j.msard.2018.03.005. Epub 2018 Mar 14.
Impact factor: 3.199
Publication type: Paper in international publication
Authors: Rasova, Kamila, Pavlikova, Marketa, Salci, Yeliz, Martinkova, Patricia, Freeman, Jenny, Drabinova, Adela, Erosheva, Elena, Cattaneo, Davide, Jonsdottir, Johanna, Baert, Ilse et al.
DOI: 10.1016/j.msard.2018.03.005

Is the impact of fatigue related to walking capacity and perceived ability in persons with multiple sclerosis? A multicenter study.

PMID: 29571860
Journal: JOURNAL OF THE NEUROLOGICAL SCIENCES
Year: 2018
Reference: J Neurol Sci. 2018 Apr 15;387:179-186. doi: 10.1016/j.jns.2018.02.026. Epub 2018 Feb 16.
Impact factor: 2.448
Publication type: Paper in international publication
Authors: Jensen, E, Baert, I, Romberg, A, Santoyo Medina, C, Gebara, B, Maertens de Noordhout, B, Knuts, K, Bethoux, F, Rasova, K, Severijns, D et al.
DOI: 10.1016/j.jns.2018.02.026

Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab.

PMID: 28643544
Journal: Multiple Sclerosis Journal
Year: 2018
Reference: Mult Scler. 2018 Mar;24(3):358-360. doi: 10.1177/1352458517711569. Epub 2017 Jun 23.
Impact factor: 5.28
Publication type: Paper in international publication
Authors: Mulero, Patricia, Auger, Cristina, Parolin, Laura, Fonseca, Elena, Requena, Manuel, Rio, Jordi, Tintore, Mar, Rovira, Alex, Montalban, Xavier et al.
DOI: 10.1177/1352458517711569

NLRP3 inflammasome is associated with the response to IFN-beta in patients with multiple sclerosis.

PMID: 25586466
Journal: BRAIN
Year: 2015
Reference: Brain. 2015 Mar;138(Pt 3):644-52. doi: 10.1093/brain/awu388. Epub 2015 Jan 12.
Impact factor: 9.196
Publication type: Paper in international publication
Authors: Chan, Andrew, Martinelli-Boneschi, Filippo, Garcia-Merino, Antonio, Montalban, Xavier, Comabella, Manuel, Drulovic, Jelena, Lechner-Scott, Jeannette, Brassat, David, Malhotra, Sunny, Rio, Jordi et al.
DOI: 10.1093/brain/awu388

Blog

News

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.

The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.

Rates

Simoa HD1 equipment

We are seeking healthy volunteers for a study to find biomarkers of multiple sclerosis

We are looking for 100 healthy volunteers aged 18 or over to participate in a project where the usefulness of biomarkers in serum will be evaluated to predict the prognosis of the disease and the response to treatments.

More information